SPARTALIZUMAB
UNII QOG25L6Z8Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Spartalizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QOG25L6Z8Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1935694-88-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QOG25L6Z8Z

CAS Registry Number

1935694-88-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SPARTALIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C121625

National Cancer Institute reference terminology for clinical and research data.

INN ID

10624

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-36

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Spartalizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SPARTALIZUMAB

Common Names & Synonyms

SPARTALIZUMAB [INN]

SPARTALIZUMAB [JAN]

SPARTALIZUMAB [USAN]

SPARTALIZUMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1)(HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS240118 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS240118 .KAPPA.-CHAIN, DIMER

SYS

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PROGRAMMED CELL DEATH PROTEIN 1 (PROTEIN PD-1, CD-279 ANTIGEN))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN (1-443) (HUMANIZED VH (HOMO SAPIENS IGHV1-69-2*01 (75%) (IGHD)-IGHJ6*01) (8.8.10) (1-117)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(225)), CH3(K107>DEL(444))) (118-443)) (131-220')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-220') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV3D-11*03 (76%) IGKJ1*01 (92%))(12.3.9) (1'-113')-HOMO SAPIENS IGKC*01 (114'-220')), DIMER (223-223'':226-226'')-BISDISULFIDE

SYS